Phaarmasia has informed that the Company is in receipt of the initial public announcement dated 11th November, 2022 made by Saffron Capital Advisors, Manager to the Offer, on behalf of Maneesh Pharmaceuticals, representing the Promoter Group of Phaarmasia (Company) in accordance with Regulation 8 of the SEBI (Delisting of Equity Shares) Regulations 2021, as amended, expressing the intention to voluntary delist the equity shares of the Company (Initial Public Announcement or IPA.
The above information is a part of company’s filings submitted to BSE.
